In his long career as a gastroenterologist, Stephen R. Targan, MD, has seen many innovations and treatments emerge in his field. But, throughout these changes over 30 years, one guiding principle has remained the same.
“The basis, really, of all I’ve done – whether it’s basic science, translational science, clinical science and research – has been based on the concept I had over 30 years ago: that this disease set is very complex and very heterogeneous,” Targan, who is the director of the Inflammatory Bowel and Immunobiology Research Center at Cedars-Sinai Medical Center, said in an interview. “In order to understand the underpinnings of these diseases, we’re going to need to have integrated scientific interactions to approach it.”
